979 PREVALENCE AND PROGNOSTIC ROLE OF COMMON TUMOR SUPPRESSOR GENE DELETIONS IN PROSTATE CANCER
โ Scribed by Schlomm, Thorsten; Kluth, Martinia; Tennstedt, Pierre; Sauter, Guido; Burkhardt, Lia; Krohn, Anje; Gjoni, Jovisa; Hass, Thomas; Galal, Rami; Simon, Ronald; Minner, Sarah
- Book ID
- 123587933
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2013
- Tongue
- English
- Weight
- 50 KB
- Volume
- 189
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
To identify whether alterations of the p16 tumor suppressor gene are a common event in localized prostate cancer, we examined the frequency of p16 gene mutations in 30 primary tumors. Only two tumors demonstrated altered single-strand conformation polymorphism patterns for exon 2 of p16. In both cas
Chromosome 9p has been reported to be a critical region of loss in various cancers. Our present study was designed to determine the frequency of deletions at different loci of chromosome 9p in microdissected samples of normal prostatic epithelium and carcinoma from the same patients. For this purpos
## Abstract ## BACKGROUND Inactivation of the tumor suppressor gene __PTEN__/__MMAC1__/__TEP1__, located on chromosome 10q23, is a common event in advanced stages of diverse human malignancies. However, the prognostic role of __PTEN__ expression in patients with hepatocellular carcinoma (HCC) has
By using tissue microdissection and polymerase chain reaction (PCR) techniques, we examined 85 prostate tumors that were paired with normal tissues from the same patients for allelic loss at 26 highly polymorphic microsatellite sequences, 21 spanning 8p and 5 localized to 8q. Sixty-four tumors (75%)
## Abstract PGP9.5 is a controversial molecule from an oncologic point of view. We recently identified frequent methylation of PGP9.5 gene exclusively in primary head and neck squamous cell carcinoma (HNSCC), suggesting that it could be a tumor suppressor gene. On the other hand, PGP9.5 was reporte